Lunai Bioworks Inc. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
Lunai Bioworks Inc. (LNAI) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $1.86 million for the 3-month period ending 2024-03-31, per its 10-Q/A filed 2025-02-19.
Financial Statements › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2025-02-19
- Lunai Bioworks Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2024-03-31 was $1.86M, a 72.98% increase year-over-year.
- Lunai Bioworks Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2023-12-31 was $999.23K, a 21.86% increase year-over-year.
- Lunai Bioworks Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2023-03-31 was $1.08M.
- Lunai Bioworks Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2022-12-31 was $819.96K.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month |
|---|---|---|---|
| 2024-03-31 | $1.86M 10-Q/A · filed 2025-02-19 | $2.86M derived: sum of 2 quarters · filed 2025-02-19 | $3.84M 10-Q/A · filed 2025-02-19 |
| 2023-12-31 | $999.23K 10-Q · filed 2024-02-14 | $1.98M 10-Q · filed 2024-02-14 | |
| 2023-03-31 | $1.08M 10-Q/A · filed 2025-02-19 | $1.90M derived: sum of 2 quarters · filed 2025-02-19 | $2.92M 10-Q/A · filed 2025-02-19 |
| 2022-12-31 | $819.96K 10-Q · filed 2024-02-14 | $1.85M 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |